ghk-cu peptide clinical evidence Frontiers GHK-Cu Clinical Profile | Copper

Animal doses are calculated per kilogram of body weight and do not scale linearly to humans

Generally speaking, there's a lot more nuance to the conversation

Routes of Administration Like many research peptides, injection of BPC-157 has historically been the favored route of administration due to the compounds instability and consequent low oral bioavailability

Further, they look at the percentage of those treated achieving 5%, 10%, 15%, and 20% or more of the total body weight

It directly kills pathogens by disrupting their cell membranes, and it modulates immune responses by influencing cytokine production, immune cell migration, and tissue healing